Skip to main content

Werewolf Therapeutics, Inc.

HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001785530

No open-market purchases or sales by Werewolf Therapeutics, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q3 2026, worth $11.9M in total; no superinvestor holds it.

13F holders, Q3 2026

Institutional positions in Werewolf Therapeutics, Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
46
+1 vs. Q2 2026
Shares held
12.9M
+1.99M (+18.3%) vs. Q2 2026
Total value
$11.9M
+$7.94M (+203.0%) vs. Q2 2026
New holders
13
15 more added
Sold out
12
5 more reduced

Compare with Q2 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting HOWL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2026: 46 institutions
Q1 2021: 0 institutionsQ2 2021: 45 institutionsQ3 2021: 42 institutionsQ4 2021: 51 institutionsQ1 2022: 49 institutionsQ2 2022: 46 institutionsQ3 2022: 44 institutionsQ4 2022: 39 institutionsQ1 2023: 38 institutionsQ2 2023: 36 institutionsQ3 2023: 35 institutionsQ4 2023: 41 institutionsQ1 2024: 61 institutionsQ2 2024: 71 institutionsQ3 2024: 69 institutionsQ4 2024: 73 institutionsQ1 2025: 70 institutionsQ2 2025: 65 institutionsQ3 2025: 62 institutionsQ4 2025: 51 institutionsQ1 2026: 48 institutionsQ2 2026: 45 institutionsQ3 2026: 46 institutions
Value heldQ3 2026: $11.9M
Q1 2021: $0Q2 2021: $344.3MQ3 2021: $326.2MQ4 2021: $228.3MQ1 2022: $83.5MQ2 2022: $78.0MQ3 2022: $94.5MQ4 2022: $42.8MQ1 2023: $62.5MQ2 2023: $73.3MQ3 2023: $51.1MQ4 2023: $106.8MQ1 2024: $209.0MQ2 2024: $79.2MQ3 2024: $68.3MQ4 2024: $41.7MQ1 2025: $26.7MQ2 2025: $24.3MQ3 2025: $41.6MQ4 2025: $9.34MQ1 2026: $11.7MQ2 2026: $3.91MQ3 2026: $11.9M
Institutions holding HOWL and their total value by quarter
QuarterHoldersValue
Q3 202646$11.9M
Q2 202645$3.91M
Q1 202648$11.7M
Q4 202551$9.34M
Q3 202562$41.6M
Q2 202565$24.3M
Q1 202570$26.7M
Q4 202473$41.7M
Q3 202469$68.3M
Q2 202471$79.2M
Q1 202461$209.0M
Q4 202341$106.8M
Q3 202335$51.1M
Q2 202336$73.3M
Q1 202338$62.5M
Q4 202239$42.8M
Q3 202244$94.5M
Q2 202246$78.0M
Q1 202249$83.5M
Q4 202151$228.3M
Q3 202142$326.2M
Q2 202145$344.3M
Q1 20210$0

Institutions, Q3 2026

Shares, value and share of portfolio for each institution holding Werewolf Therapeutics, Inc.; share changes are against Q2 2026.

Institutions holding HOWL in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Balyasny Asset Management LLC3,040,251$2.80M0.01%+1,250,162+69.8%Added
ADAR1 Capital Management, LLC2,023,331$1.87M0.08%+2,023,331New
Vanguard Capital Management LLC1,217,976$1.12M0.00%00.0%Unchanged
Lynx1 Capital Management LP657,786$606.7K0.09%00.0%Unchanged
Sphera Funds Management Ltd.626,810$578.1K0.09%00.0%Unchanged
DC Funds, LP589,102$543.3K73.28%00.0%Unchanged
Jane Street Group, LLC564,526$520.7K0.00%+312,689+124.2%Added
Citadel Advisors LLC553,702$510.7K0.00%+553,702New
Renaissance Technologies LLC550,935$508.1K0.00%−123,697−18.3%Reduced
HRT Financial LP415,191$382.0K0.00%+415,191New
Geode Capital Management, LLC407,145$375.6K0.00%+71,330+21.2%Added
Acadian Asset Management LLC316,672$291.0K0.00%+316,672New
Vanguard Fiduciary Trust Co266,666$245.9K0.00%+108,940+69.1%Added
XTX Topco Ltd209,611$193.3K0.00%−61,867−22.8%Reduced
Bank of America Corp171,631$158.2K0.00%−139,871−44.9%Reduced
BlackRock, Inc.153,234$141.3K0.00%+51,661+50.9%Added
Covestor Ltd134,212$124.0K0.08%+134,212New
State Street Corp119,168$109.9K0.00%00.0%Unchanged
Northern Trust Corp97,409$89.8K0.00%+10,558+12.2%Added
Virtu Financial LLC90,749$84.0K0.00%+45,282+99.6%Added
Alyeska Investment Group, L.P.86,554$79.8K0.00%00.0%Unchanged
Morgan Stanley69,623$64.2K0.00%+50,515+264.4%Added
Vontobel Holding Ltd.60,000$55.3K0.00%+60,000New
StoneX Group Inc.54,856$51.1K0.00%+34,856+174.3%Added
Vilga Financial Planning LLC53,423$49.3K0.03%+53,423New
UBS Group AG41,442$38.2K0.00%−174,396−80.8%Reduced
Prudential Financial Inc37,400$34.5K0.00%+37,400New
Vanguard Global Advisers, LLC30,550$28.2K0.00%+30,550New
Goldman Sachs Group Inc28,533$26.3K0.00%+8,510+42.5%Added
JPMorgan Chase & Co24,393$22.2K0.00%+22,285+1,057.2%Added
LPL Financial LLC23,069$21.3K0.00%+11,278+95.6%Added
Two Sigma Securities, LLC20,578$19.0K0.00%+20,578New
Barclays PLC20,390$18.8K0.00%+7,155+54.1%Added
HBK Sorce Advisory LLC13,737$14.0K0.00%+510+3.9%Added
Camden Capital, LLC15,000$13.8K0.00%00.0%Unchanged
Larson Financial Group LLC13,052$12.0K0.00%00.0%Unchanged
Citigroup Inc11,971$11.0K0.00%+11,971New
Marest Capital, LLC10,870$10.0K0.01%00.0%Unchanged
Boothbay Fund Management, LLC10,000$9.22K0.00%+10,000New
Advisor Group Holdings, Inc.8,625$7.93K0.00%00.0%Unchanged
Financial Perspectives, Inc6,750$6.23K0.00%00.0%Unchanged
Jones Financial Companies LLLP3,000$2.88K0.00%+3,000New
Tower Research Capital LLC (TRC)1,366$1.26K0.00%−8,531−86.2%Reduced
BNP Paribas Arbitrage, SA790$7290.00%00.0%Unchanged
SBI Securities Co., Ltd.130$1200.00%+30+30.0%Added
Optiver Holding B.V.22$200.00%00.0%Unchanged
Ra Capital Management, L.P.0$00.00%−2,387,744−100.0%Sold out
Verdad Advisers, LP0$00.00%−348,709−100.0%Sold out
Squarepoint Ops LLC0$00.00%−103,242−100.0%Sold out
Rangeley Capital, LLC0$00.00%−100,000−100.0%Sold out
MPM Oncology Impact Management LP0$00.00%−80,142−100.0%Sold out
Millennium Management LLC0$00.00%−62,055−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−27,146−100.0%Sold out
Two Sigma Investments, LP0$00.00%−27,300−100.0%Sold out
Pacitti Group Inc.0$00.00%−11,000−100.0%Sold out
Cetera Investment Advisers0$00.00%−10,200−100.0%Sold out
Group One Trading, L.P.0$00.00%−1,871−100.0%Sold out
Simplex Trading, LLC0$00.00%−255−100.0%Sold out